Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001454982-09-000112
Filing Date
2009-06-10
Accepted
2009-06-10 19:02:28
Documents
1
Period of Report
2009-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3683
  Complete submission text file 0001454982-09-000112.txt   5351
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
ALTMAN STEVEN R (Reporting) CIK: 0001191307 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 09885708